"MGV tracks 130 mega-cap stocks with strategic concentration in defensive sectors that provide stability during market uncertainty. The fund's largest bet is on financials at 21.7% of assets, positioning investors to benefit from banking sector strength as interest rates stabilize and loan demand recovers. Healthcare represents the second-largest allocation at 18.8%, adding pharmaceutical exposure through established players that generate consistent cash flows regardless of economic conditions."
"The top holdings reveal the fund's quality focus. JPMorgan Chase & Co. (NYSE:JPM) leads at 4.74% of assets, combining financial sector exposure with a track record of dividend growth. Johnson & Johnson (NYSE:JNJ)'s 2.74% weighting adds defensive healthcare characteristics, while Exxon Mobil Corp (NYSE:XOM)'s 2.72% stake provides energy diversification for portfolios seeking commodity exposure. The fund generates returns through steady dividend income and capital appreciation from undervalued companies."
MGV tracks 130 mega-cap U.S. companies and concentrates in defensive sectors to provide stability during market uncertainty. Financials comprise 21.7% of assets and healthcare 18.8%, positioning the fund to benefit from bank strength and steady pharmaceutical cash flows. Top holdings include JPMorgan Chase (4.74%), Johnson & Johnson (2.74%), and Exxon Mobil (2.72%), reflecting quality and sector diversification. The fund yields 2.02% and charges a minimal 7 basis point fee. Returns arise from steady dividend income and capital appreciation from undervalued companies, with recent performance delivering 18% over the past year and lower volatility than growth alternatives.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]